Genome edited B cells: a new frontier in immune cell therapies
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference118 articles.
1. Gene editing and CRISPR in the clinic: Current and future perspectives;Hirakawa;Biosci. Rep.,2020
2. Chimeric antigen receptor therapy;June;N. Engl. J. Med.,2018
3. CAR-T cells: Early successes in blood cancer and challenges in solid tumors;Dana;Acta Pharm. Sin. B,2021
4. Chimeric antigen receptor T-cell approaches to HIV cure;Kuhlmann;Curr. Opin. HIV AIDS,2018
5. Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo;Maldini;Nat. Med.,2020
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Relationship between B-Cell Populations, Development and Function of B-Cell Subsets;Molecular Biology of B Cells;2024
2. Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics;Advanced Science;2023-12-21
3. Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium;Molecular Therapy - Methods & Clinical Development;2023-12
4. Adenoviral vectors infect B lymphocytes in vivo;Molecular Therapy;2023-09
5. Advancing in vivo genome editing: B cell engineering via adenoviral delivery systems;Molecular Therapy;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3